Posts

Showing posts from July, 2023

Top 5 challenges In Pharmaceutical Market Research

Image
  Pharmaceutical market research  plays a crucial role in shaping the strategies and decision-making processes of pharmaceutical companies. It helps them understand the market dynamics, customer preferences, and competitive landscape. In this article, we will explore the top five challenges faced by pharmaceutical market researchers and discuss strategies to overcome them. Pharmaceutical market research faces various challenges due to the unique nature of the pharmaceutical industry. These challenges arise from factors such as the complexity of the healthcare landscape, the stringent regulatory environment, and the need for accurate and sensitive data collection. The healthcare landscape is constantly evolving, with advancements in medical technology, changing treatment guidelines, and emerging therapies. This dynamic environment poses challenges for  Pharmaceutical Market Research  as researchers must stay updated with the latest developments to provide accurate ins...

Cancer Statistics 2023: Cancer Cases and Deaths in United States

Image
  Every year, the American Cancer Society estimates the number of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes from central cancer registries and the National Centre for Health Statistics. In 2023, the United States is expected to have 1,958,310 new cancer cases and 609,820 cancer deaths. After two decades of reduction, prostate cancer incidence increased by 3% each year from 2014 to 2019, resulting in an additional 99,000 new cases; otherwise, incidence trends were more favourable in men than in women. From 2015 to 2019, for example, lung cancer in women reduced at half the rate of males (1.1% vs. 2.6% annually), whereas breast and uterine corpus cancers increased, as did liver cancer and melanoma, all of which stabilised in men aged 50 and older and declined in younger men. However, a 65% decrease in cervical cancer incidence among women in their early twenties, the first cohort to receive th...